Teligent Revenue and Competitors
Estimated Revenue & Valuation
- Teligent's estimated annual revenue is currently $75M per year.
- Teligent's estimated revenue per employee is $663,717
- Teligent's total funding is $16.1M.
Employee Data
- Teligent has 113 Employees.
- Teligent grew their employee count by -19% last year.
Teligent Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Teligent?
Startec is a facilities-based provider of communications services, including voice, data and Internet access. Founded as a corporation in 1989, we market our services to ethnic businesses, residential communities located in major metropolitan areas, to international long distance carriers and to Internet service providers transacting with the world\'s emerging economies. Our mission is to become a leading provider of Internet Protocol, (\"IP\"), communication services, including voice, data and Internet services to our targeted ethnic markets, comprised of ethnic communities from the Asia Pacific Rim, the Middle East and North Africa, Russia and Central Europe and Latin and South America.
keywords:N/A
$16.1M
Total Funding
113
Number of Employees
$75M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Teligent News
Teligent; Pfizer; B Braun; Sagent; WG Critical Care; GSK; Allergan; CSPC Zhongnuo Pharmaceutical; Anhui Welman; Guangzhou Baiyunshan Tianxin...
Generic drug maker Teligent Inc. proposed a Chapter 11 plan to liquidate following an asset sale and pay its creditors a fraction of what...
BUENA, N.J., Jan. 28, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced a series of strategic actions in partnership with its senior lenders and its Series C noteholders to recapitalize ...
BUENA, N.J., Jan. 28, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced a series of strategic actions in partnership with its senior lenders and its Series C noteholders to recapitalize ...